Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
After a median follow-up of 2.3 years, GLP-1 RAs users exhibit reduced risks of mortality (adjusted hazard ratio [aHR]: 0.57), MACEs (aHR: 0.88), and MAKEs (aHR: 0.73)
That number comes from the Phase 3 TRIUMPH-4 trial, which ran from enrollment through a full 68-week treatment period with participants receiving either 9 mg or 12 mg weekly injections
It represents a major opportunity for plant-based food producers
For glycemic control in patients with type 2 diabetes, less frequent dosing may lead to deterioration in blood glucose management
This is a cooperative breeding program, with a number of zoos working together to ensure the survival of the species
US$ 25.93
US$ 21.65
US$ 29.76
US$ 27.44
US$ 20.41
US$ 26.18
US$ 21.81
